Healthcare Wire Hong Kong: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Hong Kong.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 25, 2026

Mar. 25, 2026

Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026

GlobeNewswire

Mar. 25, 2026

LogicMark, Inc. Announces Strong Fourth Quarter and Full Year 2025 Results

GlobeNewswire

Mar. 25, 2026

Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

GlobeNewswire

Mar. 25, 2026

ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

GlobeNewswire

Mar. 25, 2026

Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire

Mar. 25, 2026

Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 25, 2026

American Nurses Enterprise Launches 2026–2030 Strategic Plan, Charting a Bold New Direction for the Future of Nursing

GlobeNewswire

Mar. 25, 2026

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

Mar. 25, 2026

Alcool : Reporter l’amendement au PL11 sur les boissons prêtes-à-boire est la meilleure chose à faire

GlobeNewswire

Mar. 25, 2026

Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration

GlobeNewswire

Mar. 25, 2026

Catalyst MedTech Establishes Full Access Neurology Solution as the Industry Standard for Brain PET Implementation in the U.S.

GlobeNewswire

Mar. 25, 2026

Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.

GlobeNewswire

Mar. 25, 2026

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

GlobeNewswire

Mar. 25, 2026

Startup Launches “Friending” App to Tackle America’s Growing Loneliness Epidemic

GlobeNewswire

Mar. 25, 2026

InhaleH₂ Earns Canadian SR&ED Recognition for Breakthrough in Hydrogen Therapy Delivery

GlobeNewswire

Mar. 25, 2026

GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD

GlobeNewswire

Mar. 25, 2026

After CBS Exposes Hospice Fraud, Industry Calls for Five Priority Guardrails to Protect Patients

GlobeNewswire

Mar. 25, 2026

NANOBIOTIX Statement Regarding Recent Media Speculation

GlobeNewswire

Mar. 25, 2026

Declaration de NANOBIOTIX concernant une recente rumeur mediatique

GlobeNewswire

Mar. 25, 2026

Top Prostate Health Supplements for Men Over 45: Natural Support for Urinary Function, Hormonal Balance & Male Vitality in 2026

GlobeNewswire